In vitro immortalization of Old World monkey T lymphocytes with Herpesvirus saimiri: its susceptibility to infection with simian immunodeficiency viruses. NLM AIDSLINE Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


In vitro immortalization of Old World monkey T lymphocytes with Herpesvirus saimiri: its susceptibility to infection with simian immunodeficiency viruses.

Virology. 1996 Apr 15;218(2):382-8. Unique Identifier : AIDSLINE MED/96193750
Akari H; Mori K; Terao K; Otani I; Fukasawa M; Mukai R; Yoshikawa Y; Tsukuba Primate Center for Medical Science, National Institute of; Health, Ibaraki, Japan.


Abstract: Peripheral blood T lymphocytes of Old World monkeys, rhesus and cynomolgus monkey (Macaca mulatta and Macaca fascicularis, respectively), were successfully immortalized by infection with Herpesvirus saimiri subtype C. The T cell lines were stably cultured without addition of exogenous IL-2. The STP-C488 protein, the oncogene product of subtype C strain 488-77, was detected in these cells by Western blotting. They also expressed some markers of activated or matured T cell phenotypes such as CD2+, monkey Pan-T+, CD25+,CD29+ and MHC-II DR+. Interestingly, not only CD4+CD8- or CD4-CD8+ single positive subpopulations but also CD4+CD8+ double positive ones were present in all of them. Furthermore, they were productively infected with both SIVmac and SIVagm. The levels of the viral replication were comparable to those in human T cell lines. Thus, Herpes Virus Saimiri-immortalized Old World monkey T lymphocytes will be suitable for further studies of immune system in Old World monkeys and cell-virus interactions in SIV infection.
Keywords: Animal Antigens, CD/ANALYSIS Cell Line, Transformed Cell Transformation, Viral/PHYSIOLOGY CD4-Positive T-Lymphocytes/*VIROLOGY CD8-Positive T-Lymphocytes/VIROLOGY Herpesvirus 2, Saimirine/GROWTH & DEVELOPMENT/*PHYSIOLOGY Human HLA-DR Antigens/ANALYSIS Leukocytes, Mononuclear/VIROLOGY Macaca fascicularis/*IMMUNOLOGY Macaca mulatta/*IMMUNOLOGY Oncogene Proteins, Viral/ANALYSIS Support, Non-U.S. Gov't Virus Replication JOURNAL ARTICLEKWDanimalantigens,cd/analysiscellline,transformedcelltransformation,viral/physiologycd4-positivet-lymphocytes/KWDvirologycd8-positivet-lymphocytes/virologyherpesvirus2,saimirine/growth&development/KWDphysiologyhumanhla-drantigens/analysisleukocytes,mononuclear/virologymacacafascicularis/KWDimmunologymacacamulatta/KWDimmunologyoncogeneproteins,viral/analysissupport,non-uKWDsKWDgov'tvirusreplicationjournalarticle
960830
M9681129

Copyright © 1996 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1996. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .